ArticleFrontiers in oncology2022

Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective study.

Lingfeng Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.